Verition Fund Management LLC Summit Therapeutics Inc. Transaction History
Verition Fund Management LLC
- $17.4 Billion
- Q3 2024
A detailed history of Verition Fund Management LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 18,677 shares of SMMT stock, worth $367,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,677Holding current value
$367,936% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
224Shares Held
80MCall Options Held
2.07MPut Options Held
3.12M-
Baker Bros. Advisors LP New York, NY24.4MShares$481 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$156 Million0.0% of portfolio
-
State Street Corp Boston, MA5.6MShares$110 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$107 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.96B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...